Eugene

[email protected]

LATEST

WuXi Biologics To Invest $60-Million in US Biomanufacturing Facility
By

By
WuXi Biologics, part of WuXi AppTec, a Shanghai, China-headquartered contract service provider, plans to invest $60 million to establish a biologics clinical and commercial manufacturing facility in Worcester, Massachusetts. The…

Cambrex Expands Generic API R&D Capabilities
By

By
Cambrex, an East Rutherford, New Jersey-based contract manufacturer of small-molecule active pharmaceutical ingredients (APIs), plans to expand research and development (R&D) capabilities at its site in Paullo, Milan, Italy. The…

Alexion, Complement Pharma Partner
By

By
Alexion Pharmaceuticals, a New Haven, Connecticut-based pharmaceutical company, and Complement Pharma, a pharmaceutical company headquartered in Amsterdam, the Netherlands, have partnered to co-develop Complement Pharma’s preclinical C6 complement inhibitor for…

FDA Commissioner Speaks on Agency’s Efforts for Patient-Focused Drug Development
By

By
The US Food and Drug Administration (FDA) has issued one of four planned draft guidances to describe how patient-experience data and other information from patients and caregivers can be collected…

FDA Commissioner Highlights Agency’s Steps Toward Value-Based Healthcare
By

By
US Food and Drug Administration (FDA) Commissioner Scott Gottlieb has outlined steps the agency is taking to advance value-based healthcare by advancing medical product communications through the issuance of two…

Vetter Launches Open-Innovation Challenge for Injectables
By

By
Vetter Pharma, a Ravensburg, Germany-headquartered contract development and manufacturing organization for aseptic filling and final packaging of injectables, has launched a challenge for developing solutions for injectables medicines that are…

Wasdell Group To Invest in New Analytical Lab
By

By
Wasdell Group, a Newcastle, UK-headquartered contract development and manufacturing organization and contract packager, plans to invest £500,000 ($668,000) in a new analytical laboratory at its Newcastle site. The 1,200 square-foot…

GE, Xiangxue Pharma Partner for Cell-Therapy Manufacturing
By

By
GE Healthcare has partnered with Xiangxue Pharmaceutical Co., a Guangzhou, China-headquartered pharmaceutical company, to provide GE’s FlexFactory platform, a semi-automated end-to-end manufacturing platform, to help scale up, digitize and accelerate…

Roche, AbbVie, AstraZeneca, Amgen Lead Drug Approval News
By

By
A roundup of the latest drug approvals, including from the pharmaceutical majors, featuring news from Roche, AbbVie, AstraZeneca, and Amgen. Editor’s Note: This article was updated on a continuous basis for…

Pfizer Leads Pipeline News
By

By
A roundup of the latest market developments from the pipelines of the pharmaceutical majors, featuring news from Pfizer. Editor’s Note: This article was updated on a continuous basis for news…